ZimVie Inc
NASDAQ:ZIMV
Intrinsic Value
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. [ Read More ]
The intrinsic value of one ZIMV stock under the Base Case scenario is 15.99 USD. Compared to the current market price of 16.51 USD, ZimVie Inc is Overvalued by 3%.
Valuation Backtest
ZimVie Inc
Run backtest to discover the historical profit from buying and selling ZIMV stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of ZimVie Inc's business.
What risks and challenges
does ZimVie Inc face in the near future?
Summarize the latest earnings report
of ZimVie Inc.
Provide P/E
for ZimVie Inc and its competitors.
Balance Sheet Decomposition
ZimVie Inc
Current Assets | 482.9m |
Cash & Short-Term Investments | 71.5m |
Receivables | 65.2m |
Other Current Assets | 346.2m |
Non-Current Assets | 722.5m |
PP&E | 54.2m |
Intangibles | 376.5m |
Other Non-Current Assets | 291.8m |
Current Liabilities | 173.6m |
Accounts Payable | 27.8m |
Accrued Liabilities | 4.1m |
Other Current Liabilities | 141.8m |
Non-Current Liabilities | 622.2m |
Long-Term Debt | 508.8m |
Other Non-Current Liabilities | 113.4m |
Earnings Waterfall
ZimVie Inc
Revenue
|
457.4m
USD
|
Cost of Revenue
|
-167.1m
USD
|
Gross Profit
|
290.4m
USD
|
Operating Expenses
|
-301.6m
USD
|
Operating Income
|
-11.3m
USD
|
Other Expenses
|
-382m
USD
|
Net Income
|
-393.3m
USD
|
Free Cash Flow Analysis
ZimVie Inc
What is Free Cash Flow?
ZIMV Profitability Score
Profitability Due Diligence
ZimVie Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
ZimVie Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
ZIMV Solvency Score
Solvency Due Diligence
ZimVie Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Score
ZimVie Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ZIMV Price Targets Summary
ZimVie Inc
According to Wall Street analysts, the average 1-year price target for ZIMV is 16.32 USD with a low forecast of 16.16 USD and a high forecast of 16.8 USD.
Ownership
ZIMV Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ZIMV Price
ZimVie Inc
Average Annual Return | -74.79% |
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -86% |
Market Capitalization | 447m USD |
Shares Outstanding | 27 000 000 |
Percentage of Shares Shorted | 2.37% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 2,700 full-time employees. The company went IPO on 2022-02-14. The firm develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.
Contact
IPO
Employees
Officers
The intrinsic value of one ZIMV stock under the Base Case scenario is 15.99 USD.
Compared to the current market price of 16.51 USD, ZimVie Inc is Overvalued by 3%.